研究目的
Investigating the safety and efficacy of Holmium laser enucleation of the prostate (HoLEP) in patients with previous transperineal biopsy (TPB).
研究成果
HoLEP is a feasible, safe, and effective treatment for benign prostatic enlargement in patients with previous TPB, with no significant differences in outcomes compared to biopsy-naive patients. Further research is needed to evaluate long-term outcomes.
研究不足
The study was limited by its retrospective data collection for some post-operative measures, missing data on IPSS/QoL scores in some patients, and the focus on short-term outcomes. Additionally, the use of 50 W low-power HoLEP may limit the applicability of results to higher-power procedures.
1:Experimental Design and Method Selection:
A dual-centre case-control study was conducted to compare outcomes of HoLEP in patients with and without previous TPB.
2:Sample Selection and Data Sources:
Data was collected for 109 patients undergoing HoLEP, stratified into two groups based on previous TPB status.
3:List of Experimental Equipment and Materials:
50 W Auriga XL laser (Boston Scientific Inc.) was used for HoLEP, and morcellation was performed with the Wolf Piranha Morcellator system.
4:Experimental Procedures and Operational Workflow:
Patients underwent HoLEP under general anaesthesia, with data collected on pre-operative, intra-operative, and post-operative measures.
5:Data Analysis Methods:
Data was analyzed using SPSS version 25 for Windows, employing parametric and non-parametric tests as appropriate.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容